NATHBIOGEN — Nath Bio-Genes (I) Balance Sheet

0.000.00%

Last trade - 00:00

Consumer DefensivesAdventurousMicro CapNeutral

Annual balance sheet for Nath Bio-Genes (I), fiscal year end - March 31st, INR millions except per share, conversion factor applied.

	2022 March 31st	2023 March 31st	2024 March 31st	2025 March 31st	2026 March 31st
Period Length:	—	—	—	—	—
Source:	ARS	ARS	ARS	ARS	PRESS
Standards:	IAS	IAS	IAS	IAS	—
Status:	Final	Final	Final	Final	Final
Cash
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	41.7	380	774	885	2,394
Net Total Accounts Receivable
Net Total Receivables	203	1,322	1,021	987	864
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	4,702	5,208	5,717	6,900	7,789
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	2,329	2,340	2,406	2,432	2,438
Net Intangible Assets
Long Term Investments
Long Term Notes Receivable
Other Long Term Assets
Total Assets	7,419	7,928	8,802	10,262	10,974
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	1,967	2,165	2,624	3,653	3,947
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Minority Interest
Total Other Liabilities
Total Funded Status
Total Liabilities	1,999	2,196	2,703	3,818	4,170
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	5,420	5,732	6,099	6,444	6,805
Total Liabilities & Shareholders' Equity	7,419	7,928	8,802	10,262	10,974
Total Common Shares Outstanding